Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:02 AM
Ignite Modification Date:
2025-12-25 @ 3:02 AM
NCT ID:
NCT06202833
Eligibility Criteria:
Inclusion Criteria:
1. sign the informed consent voluntarily;
2. met the above diagnostic criteria, and the GCS score was between 3 and 9 (the score was scored by a rehabilitation physician, and the patient had not used sedatives or anesthetics on the day of the score);
3. The patient's condition is stable, vital signs are stable, and the onset time of consciousness disturbance caused by stroke is confirmed to be less than 6 months;
4. Cerebral infarction or cerebral hemorrhage confirmed by clinical and auxiliary examination is the only factor causing consciousness disorder, excluding other diseases caused consciousness disorder patients;
5. those aged between 18 and 85;
6. Family members or authorized principals know and sign informed consent;
7. did not enter other clinical studies at the same time.
Exclusion Criteria:
1. People with consciousness impairment mainly due to changes in consciousness content or special types;
2. confirmed carbon monoxide poisoning, brain tumor, brain trauma, brain parasitic disease, metabolic disorders;
3. Patients with severe primary diseases of liver, kidney, blood system, endocrine system and other diseases with poor prognosis, mental diseases;
4. have upper gastrointestinal hemorrhage, secondary epilepsy and other serious complications;
5. Those who have venous thrombosis and are currently on anticoagulant therapy;
6. patients judged by the investigator to be unsuitable for participation in this trial;
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT06202833
Study Brief:
Protocol Section:
NCT06202833